Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / August 14, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE: VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siem...
Cellular Biomedicine (NASDAQ: CBMG ) : Q2 GAAP EPS of -$0.70 beats by $0.04 . More news on: Cellular Biomedicine Group, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
GAITHERSBURG, Md. and SHANGHAI , Aug. 12, 2020 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today repor...
Gainers: India Globalization Capital (NYSEMKT: IGC ) +174% . More news on: India Globalization Capital, Inc., Cellular Biomedicine Group, Inc., The Pennant Group, Inc., Stocks on the move, , Read more ...
NEW YORK, NY / ACCESSWIRE / August 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) to a newly-formed entity ("Parent") formed on behalf of a consortium consisting of: (i) Bizuo (Tony) Liu (CEO...
EyeGate Pharmaceuticals (NASDAQ: EYEG ) +35% on development path for conjunctivitis treatment. More news on: EyeGate Pharmaceuticals, Inc., Cellular Biomedicine Group, Inc., Vascular Biogenics Ltd., Stocks on the move, , Read more ...
Cellular Biomedicine Group (NASDAQ: CBMG ) has agreed to be acquired by a newly formed entity involving CEO Tony Liu, certain other members of management and a group of institutional investors for $19.75 per share in cash. Afterward, the group of company executives, the "Rollover Stockho...
GAITHERSBURG, Md. and SHANGHAI , Aug. 12, 2020 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("Company," "CBMG," "we" or "our"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases,...
GAITHERSBURG, Md. and SHANGHAI , July 13, 2020 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, pro...
Four names in biotechnology are seeing call-outs from Baird for potentially significant upside, and third-quarter catalysts that could give their stocks a boost. More news on: Homology Medicines, Inc., Dicerna Pharmaceuticals, Inc., Cellular Biomedicine Group, Inc., Healthcare stocks news,...
News, Short Squeeze, Breakout and More Instantly...
Cellular Biomedicine Group Inc. Company Name:
CBMG Stock Symbol:
NASDAQ Market:
Cellular Biomedicine Group Inc. Website:
Cellular Biomedicine Group, Inc. Announces Completion of Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Feb. 19, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") today announced the completion of the merger (th...
Cellular Biomedicine Group, Inc. Stockholders Approve Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Feb. 8, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") announced that, at the Company's special meeting...
Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Jan. 28, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("Company,...